Assessing the epidemiological impact on cervical cancer of switching from 4-valent to 9-valent HPV vaccine within a gender-neutral vaccination programme in Switzerland by André B. Kind, Andrew Pavelyev, Smita Kothari, Nadia El Mouaddin, Aurélie Schmidt, Edith Morais, Patrik Guggisberg, Florian Lienert

Get full text

Health Impact and Cost-Effectiveness of Implementing Gender-Neutral Vaccination With the 9-Valent Human Papillomavirus Vaccine in Belgium by Steven Simoens, Andre Bento-Abreu, Barbara Merckx, Sophie Joubert, Steve Vermeersch, Andrew Pavelyev, Andrew Pavelyev, Stefan Varga, Edith Morais

Get full text

A systematic literature review of the human papillomavirus prevalence in locally and regionally advanced and recurrent/metastatic head and neck cancers through the last decade: The... by Sofia Agelaki, Ioannis Boukovinas, Ilias Athanasiadis, Georgios Trimis, Ioannis Dimitriadis, Lazaros Poughias, Edith Morais, Ugne Sabale, Goran Bencina, Charalampos Athanasopoulos

Get full text

Estimating the prevalence of non-cervical human papillomavirus infection in mainland China (PROGRESS-Plus): protocol of a national cross-sectional study by Wei Wang, Smita Kothari-Talwar, Nuria Lara, Craig Roberts, Youlin Qiao, Fuqiang Cui, Ya-Ting Chen, Qingbin Lu, Ravi Panchal, Edith Morais

Get full text

Assessing the burden of HPV-related head and neck cancers in mainland China: protocol of a nationwide, multisite, cross-sectional study by Wei Wang, Craig Roberts, Jian Yin, Shu-Yu Wu, Yin Liu, You-Lin Qiao, Ya-Ting Chen, Zheng Su, Shao-Kai Zhang, Ravi Panchal, Edith Morais, Cheng Song, Smita Kothari

Get full text